Wednesday, February 10, 2010, 3:59pm SGT - The Singapore stock market closes in 1 hour and 1 minute.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Biovail Corporation (BVF)

At 5:01AM SGT: 13.94 USD  Up 0.20 (1.46%)  
 MORE ON BVF 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 BIOVAIL CORP (NYSE:BVF) Delayed quote dataEdit
After Hours: 13.90 Down 0.04 (0.31%) as of 5:53am SGT on 02/10/10
Last Trade:13.94 USD
Trade Time:5:01AM SGT
Change:Up 0.20 (1.46%)
Prev Close:13.74
Open:13.87
Bid:N/A
Ask:N/A
1y Target Est:16.21
Day's Range:13.74 - 14.04
52wk Range:9.26 - 16.14
Volume:752,237
Avg Vol (3m):1,189,200
Market Cap:2.21B
P/E (ttm):9.87
EPS (ttm):1.41
Div & Yield:0.65 (4.69%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add BVF to Portfolio   Download Data

 HEADLINES 
•Personalized Medicine Through Molecular Diagnostics Growth Rates Should Improve As Unemployment Eases According To Leading Industry Expert From Natixis Bleichroeder
Wall Street Transcript (Mon, Jan 25)
•UPDATE - Biovail says rival generic drug trial too small
at Reuters (Sat, Jan 23)
•Biovail Comments on Proposed Generic Wellbutrin XL® Trial
Business Wire (Sat, Jan 23)
•Study: orphan drug applications doubled in 200s
AP (Thu, Jan 21)
•MedGenesis, Amgen sign partnership
AP (Wed, Jan 13)
•Sector Snap: Generic drugmakers downgraded
AP (Sat, Jan 9)
•Biovail to Present at JPMorgan Healthcare Conference
Business Wire (Thu, Jan 7)
•Zacks #5 Rank Additions for Wednesday
Zacks.com (Wed, Jan 6)
•4-Star Stocks on the Upswing
at Motley Fool (Thu, Dec 31)
•Scammers Prey on Health Conscious
at Minyanville.com (Thu, Dec 31)
•Coverage initiated on Biovail by Thomas Weisel
Briefing.com (Thu, Dec 17)
More Headlines for BVF...
 ANALYST 
EPS Est (next year) (Dec-09) :1.30
EPS Est (in 2 years) (Dec-10) :1.32
Avg Rec (current)*:1.9
PEG Ratio:1.61
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Biovail Corporation, a pharmaceutical company, engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products principally in the United States and Canada.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices